Recently an expert opinion published in the Journal of Association of Chest Physicians titled as ‘Expert opinion on the role of bilastine and bilastine-montelukast combination in the management of allergic rhinitis: An Indian perspective’. It stated that the synergistic combination of bilastine-montelukast therapy can have a dual action on early- and late-phase allergic reactions in AR patients. This combination is an attractive treatment option in allergic rhinitis patients with asthma.